INSP Quote, Financials, Valuation and Earnings

CONMED Corp. has a net margin of 50.58% compared to Inspire Medical Systems, Inc.'s net margin of 4.48%. Inspire Medical Systems, Inc.'s return on equity of 21.07% beat CONMED Corp.'s return on equity of 4.72%.

Inspire Medical Systems, Inc. has a consensus price target of $77.86, signalling upside risk potential of 21.05%. On the other hand CONMED Corp. has an analysts' consensus of $47.40 which suggests that it could grow by 10.26%. Given that Inspire Medical Systems, Inc. has higher upside potential than CONMED Corp., analysts believe Inspire Medical Systems, Inc. is more attractive than CONMED Corp..

Inspire Medical Systems, Inc. has a beta of 0.742, which suggesting that the stock is 25.753% less volatile than S&P 500. In comparison CONMED Corp. has a beta of 0.913, suggesting its less volatile than the S&P 500 by 8.698%.

Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CONMED Corp. offers a yield of 1.86% to investors and pays a quarterly dividend of $0.20 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. CONMED Corp. pays out 18.82% of its earnings as a dividend. CONMED Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Inspire Medical Systems, Inc. quarterly revenues are $269.1M, which are smaller than CONMED Corp. quarterly revenues of $373.5M. Inspire Medical Systems, Inc.'s net income of $136.1M is higher than CONMED Corp.'s net income of $16.7M. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 12.96x while CONMED Corp.'s PE ratio is 28.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 2.09x versus 0.97x for CONMED Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Escalon Medical Corp. has a net margin of 50.58% compared to Inspire Medical Systems, Inc.'s net margin of 2.72%. Inspire Medical Systems, Inc.'s return on equity of 21.07% beat Escalon Medical Corp.'s return on equity of -12.94%.

Inspire Medical Systems, Inc. has a consensus price target of $77.86, signalling upside risk potential of 21.05%. On the other hand Escalon Medical Corp. has an analysts' consensus of -- which suggests that it could grow by 5117.39%. Given that Escalon Medical Corp. has higher upside potential than Inspire Medical Systems, Inc., analysts believe Escalon Medical Corp. is more attractive than Inspire Medical Systems, Inc..

Inspire Medical Systems, Inc. has a beta of 0.742, which suggesting that the stock is 25.753% less volatile than S&P 500. In comparison Escalon Medical Corp. has a beta of 0.232, suggesting its less volatile than the S&P 500 by 76.837%.

Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Escalon Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. Escalon Medical Corp. pays out -- of its earnings as a dividend.

Inspire Medical Systems, Inc. quarterly revenues are $269.1M, which are larger than Escalon Medical Corp. quarterly revenues of $3.6M. Inspire Medical Systems, Inc.'s net income of $136.1M is higher than Escalon Medical Corp.'s net income of $97.7K. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 12.96x while Escalon Medical Corp.'s PE ratio is 154.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 2.09x versus 0.20x for Escalon Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.

IRIDEX Corp. has a net margin of 50.58% compared to Inspire Medical Systems, Inc.'s net margin of -12.6%. Inspire Medical Systems, Inc.'s return on equity of 21.07% beat IRIDEX Corp.'s return on equity of -155.93%.

Inspire Medical Systems, Inc. has a consensus price target of $77.86, signalling upside risk potential of 21.05%. On the other hand IRIDEX Corp. has an analysts' consensus of $3.00 which suggests that it could grow by 112.77%. Given that IRIDEX Corp. has higher upside potential than Inspire Medical Systems, Inc., analysts believe IRIDEX Corp. is more attractive than Inspire Medical Systems, Inc..

Inspire Medical Systems, Inc. has a beta of 0.742, which suggesting that the stock is 25.753% less volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.674, suggesting its less volatile than the S&P 500 by 32.591%.

Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.

Inspire Medical Systems, Inc. quarterly revenues are $269.1M, which are larger than IRIDEX Corp. quarterly revenues of $12.5M. Inspire Medical Systems, Inc.'s net income of $136.1M is higher than IRIDEX Corp.'s net income of -$1.6M. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 12.96x while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 2.09x versus 0.47x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.